Literature DB >> 10592362

Ehrlichia chaffeensis in a renal transplant recipient.

R Sadikot1, M J Shaver, W B Reeves.   

Abstract

Since its first description in human beings in 1986, ehrlichiosis is now increasingly recognized as a cause of tick-borne febrile illnesses. However, the disease has been reported only rarely in immunosuppressed patients. We report a case of human ehrlichiosis in a patient with a cadaveric renal transplant. The diagnosis was confirmed initially by a positive polymerase chain reaction (PCR) for E. chaffeensis. The antibody titer became positive several weeks later. The patient responded promptly to treatment with doxycycline. Ehrlichiosis should be considered in the differential diagnosis of an acute febrile illness in transplant recipients. PCR provides a rapid means to confirm the diagnosis, particularly in settings in which antibody response may be suppressed. Copyright 1999 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10592362     DOI: 10.1159/000013540

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  7 in total

1.  Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007.

Authors:  F Scott Dahlgren; Eric J Mandel; John W Krebs; Robert F Massung; Jennifer H McQuiston
Journal:  Am J Trop Med Hyg       Date:  2011-07       Impact factor: 2.345

2.  Increasing Incidence of Ehrlichiosis in the United States: A Summary of National Surveillance of Ehrlichia chaffeensis and Ehrlichia ewingii Infections in the United States, 2008-2012.

Authors:  Kristen Nichols Heitman; F Scott Dahlgren; Naomi A Drexler; Robert F Massung; Casey Barton Behravesh
Journal:  Am J Trop Med Hyg       Date:  2015-11-30       Impact factor: 2.345

Review 3.  Severe Ehrlichia chaffeensis infection in a lung transplant recipient: a review of ehrlichiosis in the immunocompromised patient.

Authors:  Nasia Safdar; Robert B Love; Dennis G Maki
Journal:  Emerg Infect Dis       Date:  2002-03       Impact factor: 6.883

Review 4.  Ehrlichia chaffeensis: a prototypical emerging pathogen.

Authors:  Christopher D Paddock; James E Childs
Journal:  Clin Microbiol Rev       Date:  2003-01       Impact factor: 26.132

5.  Donor-derived Ehrlichiosis: 2 Clusters Following Solid Organ Transplantation.

Authors:  Aditi Saha; Charles Browning; Raja Dandamudi; Kevin Barton; Kevin Graepel; Madeline Cullity; Wala Abusalah; Du Christine; Carla Rossi; Naomi Drexler; Sridhar V Basavaraju; Pallavi Annambhotia; Rodrigo Vazquez Guillamet; Albert J Eid; Joseph Maliakkal; Aaron Miller; Christopher Hugge; Vikas R Dharnidharka; Praveen Kandula; Michael J Moritz
Journal:  Clin Infect Dis       Date:  2022-03-09       Impact factor: 20.999

6.  Ehrlichia chaffeensis infections among HIV-infected patients in a human monocytic ehrlichiosis-endemic area.

Authors:  Thomas R Talbot; James A Comer; Karen C Bloch
Journal:  Emerg Infect Dis       Date:  2003-09       Impact factor: 6.883

7.  Assessment of Risk Factors and Outcomes of Severe Ehrlichiosis Infection.

Authors:  Kevin Kuriakose; April C Pettit; Jonathan Schmitz; Abelardo Moncayo; Karen C Bloch
Journal:  JAMA Netw Open       Date:  2020-11-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.